SCHEMBL32665232

SCHEMBL32665232

C=C(C)c1ccc(-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXRA P19793 6/20 0.61
RXRB P28702 5/20 0.61
HSD17B10 Q99714 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 1/20 0.56
BCL2L1 Q07817 1/20 0.56
BAD Q92934 1/20 0.56
TP53 P04637 1/20 0.55
TSHR P16473 1/20 0.55
SRD5A2 P31213 2/20 0.50
RXRG P48443 1/20 0.50
MAPT P10636 1/20 0.50
RARB P10826 2/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL381410 0.93 ALDH1A1 (0.64) RXRARXRBHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL9516265 0.85 MAPT (0.44) RXRARXRBHSD17B10SMN1; SMN2ALDH1A1
Benzoic Acid SCHEMBL27685685 0.84 TSHR (0.67) SMN1; SMN2ALDH1A1TP53TSHRSRD5A2
Terephthalic Acid SCHEMBL1929898 0.83 TSHR (0.71) SMN1; SMN2ALDH1A1TP53TSHRSRD5A2
Terephthalic Acid SCHEMBL4438514 0.83 TSHR (0.71) SMN1; SMN2ALDH1A1TP53TSHRSRD5A2
SCHEMBL2637326 0.83 TSHR (0.80) RXRARXRBHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL69873 0.83 TSHR (0.80) RXRARXRBHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL14018385 0.83 TSHR (0.80) RXRARXRBHSD17B10SMN1; SMN2ALDH1A1
Terephthalic Acid SCHEMBL9577834 0.83 TSHR (0.80) RXRARXRBHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL18708515 0.82 NPC1 (0.70) RXRARXRBSMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022138-A1 METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE CONWAY DAVID JONATHAN (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022138-A1 METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE TRPV3, VDR, TRPC3 RXRA 378/4885RXRB 368/4885HSD17B10 4008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.